Conclusion: The Evolving Landscape of Weight Loss Treatment The development of GLP-1 medications, dual GIP/GLP-1 agonists, and emerging triple-agonist medications represents one of the most significant advances in obesity medicine in decades
Long-term Studies and Future Directions Gerstein, H
Drug Interactions Generic Semaglutide Pen 0.25 mg / 0.5 mg may interact with other antidiabetic medications and drugs affecting gastric emptying
11 Besides, gut dysbiosis is discovered in multiple gut brain axis-related diseases including Parkinsons disease (PD), 12 Alzheimers disease (AD), 13 amyotrophic lateral sclerosis, 14 autism, 15 stroke, 16 depression, 17 and drug addiction
Regular Exercise: Moderate physical activity can help boost the body's natural antioxidant defenses over time
Science 357(6349):eaaf9794